BL
Belite Bio, Inc (BLTE)
NASDAQ·Healthcare·Biotechnology
$170.80
-2.59%
Mkt Cap $6.72B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (17 analysts)
$238.33
Range $206.00 – $303.00
Implied Upside
+39.5%
Consensus $238.33 vs current $170.80
NASDAQ·Healthcare·Biotechnology
$170.80
-2.59%
Mkt Cap $6.72B
Buy
5
Hold
0
Sell
0
Price Target (17 analysts)
$238.33
Range $206.00 – $303.00
+39.5%
Consensus $238.33 vs current $170.80